Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cutler

Showing results (151-160 of 217) with videos related to

Pageof 22
Sort By:
Arthritis and Rheumatism|July 24, 2001
Stratification of flare intensity identifies placebo responders in a treatment efficacy trial of patients with osteoarthritisJ A Scott-Lennox, C McLaughlin-Miley, R D Lennox, et al.
Clinical Therapeutics|September 19, 2018
Pharmacokinetics of Single-dose Ertugliflozin in Patients With Hepatic ImpairmentVaishali Sahasrabudhe, Steven G Terra, Anne Hickman, et al.
European Journal of Clinical Pharmacology|September 22, 2011
Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjectsTeddy Kosoglou, Larisa Reyderman, Renger G Tiessen, et al.
Chest|October 1, 2013
Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhalerTeddy Kosoglou, James Hubbell, David L Cutler, et al.
Clinical Therapeutics|September 2, 2018
Effect of Rifampin on the Pharmacokinetics of Ertugliflozin in Healthy SubjectsVikas K Dawra, Vaishali Sahasrabudhe, Yali Liang, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 11, 1998
Spontaneous and inducible cytokine responses in healthy humans receiving a single dose of IFN-alpha2b: increased production of interleukin-1 receptor antagonist and suppression of IL-1-induced IL-8L L Reznikov, A J Puren, G Fantuzzi, et al.
Current Medical Research and Opinion|June 18, 2004
Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatinTeddy Kosoglou, Paul Statkevich, Ingo Meyer, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|June 3, 2016
A Qualitative Study of Factors Affecting Morale in Psychiatry Residency TrainingRachel A Caravella, Lee A Robinson, Ilene Wilets, et al.
Journal of Applied Biomechanics|July 11, 2018
Gait Mechanics Differences Between Healthy Controls and Patients With Peripheral Artery Disease After Adjusting for Gait Velocity Stride Length and Step WidthJohn D McCamley, Eric L Cutler, Kendra K Schmid, et al.
Advances in Health Sciences Education : Theory and Practice|September 4, 2008
Discrediting the notion "working with 'crazies' will make you 'crazy'": addressing stigma and enhancing empathy in medical student educationJanis L Cutler, Kelli J Harding, Sharon A Mozian, et al.
Pageof 22

Showing results (151-160 of 217) with videos related to

Sort By:
Pageof 22
Arthritis and Rheumatism|July 24, 2001
Stratification of flare intensity identifies placebo responders in a treatment efficacy trial of patients with osteoarthritisJ A Scott-Lennox, C McLaughlin-Miley, R D Lennox, et al.
Clinical Therapeutics|September 19, 2018
Pharmacokinetics of Single-dose Ertugliflozin in Patients With Hepatic ImpairmentVaishali Sahasrabudhe, Steven G Terra, Anne Hickman, et al.
European Journal of Clinical Pharmacology|September 22, 2011
Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjectsTeddy Kosoglou, Larisa Reyderman, Renger G Tiessen, et al.
Chest|October 1, 2013
Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhalerTeddy Kosoglou, James Hubbell, David L Cutler, et al.
Clinical Therapeutics|September 2, 2018
Effect of Rifampin on the Pharmacokinetics of Ertugliflozin in Healthy SubjectsVikas K Dawra, Vaishali Sahasrabudhe, Yali Liang, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 11, 1998
Spontaneous and inducible cytokine responses in healthy humans receiving a single dose of IFN-alpha2b: increased production of interleukin-1 receptor antagonist and suppression of IL-1-induced IL-8L L Reznikov, A J Puren, G Fantuzzi, et al.
Current Medical Research and Opinion|June 18, 2004
Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatinTeddy Kosoglou, Paul Statkevich, Ingo Meyer, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|June 3, 2016
A Qualitative Study of Factors Affecting Morale in Psychiatry Residency TrainingRachel A Caravella, Lee A Robinson, Ilene Wilets, et al.
Journal of Applied Biomechanics|July 11, 2018
Gait Mechanics Differences Between Healthy Controls and Patients With Peripheral Artery Disease After Adjusting for Gait Velocity Stride Length and Step WidthJohn D McCamley, Eric L Cutler, Kendra K Schmid, et al.
Advances in Health Sciences Education : Theory and Practice|September 4, 2008
Discrediting the notion "working with 'crazies' will make you 'crazy'": addressing stigma and enhancing empathy in medical student educationJanis L Cutler, Kelli J Harding, Sharon A Mozian, et al.
Pageof 22